Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: DMED )

0.0400 +0.0100 (+33.33%)
Streaming Delayed Price Updated: 10:18 AM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,150
Open 0.0350
Bid (Size) 0.0350 (45,000)
Ask (Size) 0.0400 (4,000)
Prev. Close 0.0300
Today's Range 0.0350 - 0.0400
52wk Range 0.0050 - 0.0700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Resignation of Director and Grant of Stock Options
From DiagnaMed Holdings Corp.
Via GlobeNewswire

Performance

YTD
+14.29%
+14.29%
1 Month
+60.00%
+60.00%
3 Month
+100.00%
+100.00%
6 Month
+166.67%
+166.67%
1 Year
+33.33%
+33.33%

More News

Read More
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Advancing the Medical Potential of Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Expands with Drug and Clinical Research AI Platform
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces LIFE Offering of up to $650,000
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.